The Use of Next-Generation Sequencing in Treating Non-Squamous Non-Small-Cell Lung Cancer

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Drs. Goeffrey Oxnard and Lauren Ritterhouse consider how next-generation sequencing (NGS) informs treatment of lung cancer patients in providing information on tumor mutational burden, microsatellite instability, unique targetable genomic signatures, as well as novel targets that may be best addressed in a clinical trial.

Related Videos

July 29, 2015

How to Improve the Cost of Cancer Treatments

Dr. Alex Adjei addresses the high cost of cancer medicines and suggests various ways to improve cost-effectiveness.

October 7, 2016

Tailoring Treatment Regimens for Patients with HR+/HER2-Negative Metastatic Breast Cancer

Dr Sunil Verma identifies how he makes treatment decisions for his patients, noting that he tends to use endocrine treatments instead of chemotherapy.